A Critique of the Research Article: Methadone/Buprenorphine and Better Maternal/ Perinatal Outcomes: A Meta-analysis
Winston-Salem State University
A Critique of the Research Article: Methadone/Buprenorphine and Better Maternal/ Perinatal Outcomes: A Meta-analysis Abstract
The purpose of this research article is to discuss lower risk drugs such as Methadone and Buprenorphine given to Heroin addicted pregnant patients to create better neonatal and maternal outcomes. This research articles discusses the gold standard of treatment for better neonatal and maternal outcomes. Keywords: heroin, neonatal, maternal, outcomes, methadone, buprenorphine, gold standard treatment
A Critique of the Research Article: Methadone/Buprenorphine and Better Maternal/ Perinatal Outcomes: A Meta-analysis Methadone is a synthetic opioid. It is used medically as an analgesic and a maintenance anti-addictive and reductive preparation for use by patients with opioid dependency. It was developed in Germany in 1937. Methadone was introduced into the United States in 1947 by Eli Lilly and Company. The principal effects of methadone maintenance are to relieve narcotic craving, suppress the abstinence syndrome, and block the euphoric effects associated with opiates. When used correctly, Methadone maintenance has been found to be medically safe and non-sedating. It is also indicated for pregnant women addicted to opiates. (doi:http//en.wikipedia.org/wiki/methadone) The theoretical study was not discussed in the articles but Roy’s Model identifies the elements considered essential to adaptation and describes how the elements interact to produce adaptation and thus health. Methadone helps the pregnant opioid dependent individual adapt to a lower risk drug and produces an overall healthier maternal and prenatal outcome. Middle Range Theory is less abstract and narrowed in the scope than conceptual models. These types of theories focus on answering...
Please join StudyMode to read the full document